Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis
- 31 January 1996
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (1), 84-91
- https://doi.org/10.1016/s0272-6386(96)90034-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Triglycerides, small dense LDL, and coronary heart diseaseAtherosclerosis, 1994
- Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failureKidney International, 1992
- Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and DialysisNephron, 1991
- Lipids, lipoproteins and apolipoproteins A-1 and B and apolipoprotein losses in continuous ambulatory peritoneal dialysisAtherosclerosis, 1989
- Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysisAtherosclerosis, 1987
- Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivityDiabetes, 1986
- Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.Journal of Clinical Investigation, 1986
- Increased Lipoprotein-Remnant Formation in Chronic Renal FailureNew England Journal of Medicine, 1982
- Insulin resistance in uremia mediated by postbinding defectsKidney International, 1982
- Hyperlipoproteinemia in Renal InsufficiencyNephron, 1980